NewsRx Logo Login/Signup
Home Newsletters Products Library About Us Contact -- Search NewsRx

NewsRx | Free Trials
Advertisement
VerticalNews | Global Warming
Advertisement
NewsRx | Free Trials
Advertisement
----------
------------
NewsRx on Facebook
-----
Press Release Submissions
PR Login
*
*

Law & Health Weekly

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Law & Health Weekly

Learn More

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now



Amino Up Chemical Co.



Men on "watchful waiting" eligible for soy-mushroom extract trial



June 26th, 2004

Men who are on active surveillance or "watchful waiting" for prostate cancer may be eligible to enroll in a University of California (UC) Davis Cancer Center clinical trial of genistein concentrated polysaccharide, or GCP, a food extract derived from soybeans and shiitake mushrooms.

The new study builds on a preliminary trial, completed last year, that found GCP reduced levels of prostate-specific antigen in a small group of "watchful waiting" patients.

Watchful waiting is recommended for some prostate cancers that cause no symptoms, are expected to grow very slowly, and are small and contained within one area of the prostate. Prostate-specific...


Source: Law & Health Weekly (2004-06-26)

NewsRx Passes
Advertisement
More Articles

------------------------
Security by Verisign PR Login